Kord E, Jung N, Posielski N, Jiang J, Elsamanoudi S, Chesnut G
Eur Urol Open Sci. 2023; 48:60-69.
PMID: 36743401
PMC: 9895767.
DOI: 10.1016/j.euros.2022.12.006.
Posielski N, Shanmuga S, Ho O, Jiang J, Elsamanoudi S, Speir R
Prostate Cancer Prostatic Dis. 2022; 26(2):415-420.
PMID: 36357592
DOI: 10.1038/s41391-022-00608-4.
Oehrlein N, Streicher S, Kuo H, Chaurasia A, McFadden J, Nousome D
Cancer Med. 2022; 11(22):4354-4365.
PMID: 35638719
PMC: 9678085.
DOI: 10.1002/cam4.4787.
Anderson A, Grazal C, Wedin R, Kuo C, Chen Y, Christensen B
BMC Cancer. 2022; 22(1):476.
PMID: 35490227
PMC: 9055684.
DOI: 10.1186/s12885-022-09491-7.
Kohaar I, Zhang X, Tan S, Nousome D, Babcock K, Ravindranath L
Nat Commun. 2022; 13(1):1361.
PMID: 35292633
PMC: 8924169.
DOI: 10.1038/s41467-022-28945-x.
Race, tumor location, and disease progression among low-risk prostate cancer patients.
Mygatt J, Cullen J, Streicher S, Kuo H, Chen Y, Young D
Cancer Med. 2020; 9(6):2235-2242.
PMID: 31965751
PMC: 7064097.
DOI: 10.1002/cam4.2864.
Alkaline Phosphatase Kinetics Predict Metastasis among Prostate Cancer Patients Who Experience Relapse following Radical Prostatectomy.
Salter C, Cullen J, Kuo C, Chen Y, Hurwitz L, Metwalli A
Biomed Res Int. 2018; 2018:4727089.
PMID: 30050933
PMC: 6046170.
DOI: 10.1155/2018/4727089.
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.
Cullen J, Young D, Chen Y, Degon M, Farrell J, Sedarsky J
Eur Urol Focus. 2017; 4(6):818-824.
PMID: 28753864
PMC: 7061732.
DOI: 10.1016/j.euf.2017.02.016.
Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.
Jeldres C, Cullen J, Hurwitz L, Wolff E, Levie K, Odem-Davis K
Cancer. 2015; 121(14):2465-73.
PMID: 25845467
PMC: 4490040.
DOI: 10.1002/cncr.29370.
Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancer.
Metwalli A, Rosner I, Cullen J, Chen Y, Brand T, Brassell S
Urol Oncol. 2014; 32(6):761-8.
PMID: 24929891
PMC: 4129955.
DOI: 10.1016/j.urolonc.2014.03.024.
Development of prostate cancer research database with the clinical data warehouse technology for direct linkage with electronic medical record system.
Choi I, Park S, Park B, Chung B, Kim C, Lee H
Prostate Int. 2013; 1(2):59-64.
PMID: 24223403
PMC: 3814112.
DOI: 10.12954/PI.12015.
Racial/Ethnic patterns in prostate cancer outcomes in an active surveillance cohort.
Cullen J, Brassell S, Chen Y, Porter C, LEsperance J, Brand T
Prostate Cancer. 2011; 2011:234519.
PMID: 22096650
PMC: 3195388.
DOI: 10.1155/2011/234519.
Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database.
Antonarakis E, Chen Y, Elsamanoudi S, Brassell S, Da Rocha M, Eisenberger M
BJU Int. 2010; 108(3):378-85.
PMID: 21091976
PMC: 3402027.
DOI: 10.1111/j.1464-410X.2010.09878.x.